Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Knöchel

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Plos Computational Biology|February 5, 2024
Index analysis: An approach to understand signal transduction with application to the EGFR signalling pathwayJane Knöchel, Charlotte Kloft, Wilhelm Huisinga
Journal of Pharmacokinetics and Pharmacodynamics|December 16, 2017
Understanding and reducing complex systems pharmacology models based on a novel input-response indexJane Knöchel, Charlotte Kloft, Wilhelm Huisinga
CPT: Pharmacometrics & Systems Pharmacology|January 22, 2026
Tackling High Dimensionality in QSP: Guiding Model Order Reduction With Index AnalysisJohannes Tillil, Wilhelm Huisinga, Jane Knöchel
CPT: Pharmacometrics & Systems Pharmacology|March 3, 2023
Deriving mechanism-based pharmacodynamic models by reducing quantitative systems pharmacology models: An application to warfarinUndine Falkenhagen, Jane Knöchel, Charlotte Kloft, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 18, 2024
Recent applications of pharmacometrics and systems pharmacology approaches to improve and optimize drug therapy for pregnant and lactating womenPriya Jayachandran, Jane Knöchel, Brian Cicali, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 19, 2024
Enhancing inclusivity in clinical trials: Model-informed drug development for pregnant individuals in the era of personalized medicineAndré Dallmann, Peter L Bonate, Janelle Burnham, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 18, 2025
The Advance of In Silico Evidence to Transform Pediatric Drug Development for Rare DiseasesJane Knöchel, Ping Zhao, Rajat Desikan, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 5, 2025
A Case Study of Model-Informed Drug Development of a Novel PCSK9 Antisense Oligonucleotide. Part 2: Phase 2 to Phase 3Jane Knöchel, Catarina Nilsson, Björn Carlsson, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 4, 2025
Transforming Pediatric Rare Disease Drug Development: Enhancing Clinical Trials and Regulatory Evidence With Virtual PatientsFianne Sips, Marco Virgolin, Giuseppe Pasculli, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 26, 2023
A Markov model of fibrosis development in nonalcoholic fatty liver disease predicts fibrosis progression in clinical cohortsJane Knöchel, Linnéa Bergenholm, Eman Ibrahim, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Plos Computational Biology|February 5, 2024
Index analysis: An approach to understand signal transduction with application to the EGFR signalling pathwayJane Knöchel, Charlotte Kloft, Wilhelm Huisinga
Journal of Pharmacokinetics and Pharmacodynamics|December 16, 2017
Understanding and reducing complex systems pharmacology models based on a novel input-response indexJane Knöchel, Charlotte Kloft, Wilhelm Huisinga
CPT: Pharmacometrics & Systems Pharmacology|January 22, 2026
Tackling High Dimensionality in QSP: Guiding Model Order Reduction With Index AnalysisJohannes Tillil, Wilhelm Huisinga, Jane Knöchel
CPT: Pharmacometrics & Systems Pharmacology|March 3, 2023
Deriving mechanism-based pharmacodynamic models by reducing quantitative systems pharmacology models: An application to warfarinUndine Falkenhagen, Jane Knöchel, Charlotte Kloft, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 18, 2024
Recent applications of pharmacometrics and systems pharmacology approaches to improve and optimize drug therapy for pregnant and lactating womenPriya Jayachandran, Jane Knöchel, Brian Cicali, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 19, 2024
Enhancing inclusivity in clinical trials: Model-informed drug development for pregnant individuals in the era of personalized medicineAndré Dallmann, Peter L Bonate, Janelle Burnham, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 18, 2025
The Advance of In Silico Evidence to Transform Pediatric Drug Development for Rare DiseasesJane Knöchel, Ping Zhao, Rajat Desikan, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 5, 2025
A Case Study of Model-Informed Drug Development of a Novel PCSK9 Antisense Oligonucleotide. Part 2: Phase 2 to Phase 3Jane Knöchel, Catarina Nilsson, Björn Carlsson, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 4, 2025
Transforming Pediatric Rare Disease Drug Development: Enhancing Clinical Trials and Regulatory Evidence With Virtual PatientsFianne Sips, Marco Virgolin, Giuseppe Pasculli, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 26, 2023
A Markov model of fibrosis development in nonalcoholic fatty liver disease predicts fibrosis progression in clinical cohortsJane Knöchel, Linnéa Bergenholm, Eman Ibrahim, et al.
Pageof 3